(SOURCE: UNIVERSITY OF ILLINOIS AT CHICAGO) – A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS – a progressive, neurodegenerative disease. Researchers at the University of Illinois at Chicago College of Medicine report that in a mouse model of ALS, the compound butyrate helped correct […]
(VIRGINIA TECH) According to a recent press release, researchers at the Virginia Tech Carilion Research Institute have identified a naturally occurring molecule that has the potential for preserving sites of communication between nerves and muscles in amyotrophic lateral sclerosis (ALS) and over the course of aging — as well as a molecule that interferes with […]
(UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE) According to a recent press release, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive, fatal neurological disease that attacks the nerve cells controlling voluntary muscles. No effective treatments have been found.
(News Medical Life Sciences) According to a recent article in News Medical Life Sciences, Cedars-Sinai regenerative medicine investigators have received approval from the FDA to test a combination stem cell-gene therapy they developed to stall the progression of amyotrophic lateral sclerosis, a neurological disease that causes progressive paralysis and ultimately death.
(Science Daily) According to a recent article published in Science Daily, even though only 10 percent of amyotrophic lateral sclerosis (ALS) cases are hereditary, there are a significant number which are caused by mutations that affect proteins that bind RNA, a type of genetic material.
(ALS News Today) According to a recent article published in ALS News Today, patients with amyotrophic lateral sclerosis (ALS) who have progressed to a stage in which they’ve lost all voluntary movements, including the ability to communicate, have damage in numerous brain regions and isn’t limited to motor neurons.
(Medical News Today) According to a recent study and article published in Medical News Today, pioneering research led by The University of Sheffield in the United Kingdom reveals that a type of cell in the central nervous system that usually supports motor neuron function can “go rogue” and destroy motor neurons in people with ALS.
(Medical News Today) According to a recently published article in Medical News Today, researchers from the University of North Carolina (UNC) School of Medicine have uncovered new findings which may help lead to prevention and treatment strategies for ALS SOD1 Mutations.